Effect of physical exercise versus no exercise on blood parameters in hemodialysis patients

Effect of physical exercise versus no exercise on blood parameters in hemodialysis patients: a randomized clinical trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201506139014N69

Enrollment

Registered

2015-06-18

Start date

2015-02-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis. Extracorporeal dialysis

Interventions

Intervention 1: Routine hemodialysis plus physical activity 3 sessions a week for 4 weeks. Intervention 2: Routine hemodialysis alone without physical activity.

Routine hemodialysis plus physical activity 3 sessions a week for 4 weeks

Routine hemodialysis alone without physical activity

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: (a) age of 18 to 65 years; (b) history of hemodialysis for at least 3 months; (C) serum ferritin level between 200 to 400 ng/dl. Exclusion criteria: (a) not participating in the program for 2 consecutive sessions or three sequential sessions; (b) need to kidney transplantation; (c) hiving cardiovascular diseases or musculoskeletal disorders; (d) history of cerebral ischemia during the last 3 months; (e) contraindication for physical activity.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Assessing the RBC. Timepoint: before and one month after beginning of intervention. Method of measurement: through laboratory techniques.;Assessing the WBC. Timepoint: before and one month after beginning of intervention. Method of measurement: through laboratory techniques.;Assessing the hemoglobin. Timepoint: before and one month after beginning of intervention. Method of measurement: through laboratory techniques.;Assessing the hematocrit. Timepoint: before and one month after beginning of intervention. Method of measurement: through laboratory techniques.;Assessing the platelet. Timepoint: before and one month after beginning of intervention. Method of measurement: through laboratory techniques.;Assessing the BUN. Timepoint: before and one month after beginning of intervention. Method of measurement: through laboratory techniques.;Assessing the creatinine. Timepoint: before and one month after beginning of intervention. Method of measurement: through laboratory techniques.	—

Measure

Time frame

Assessing the RBC. Timepoint: before and one month after beginning of intervention. Method of measurement: through laboratory techniques.;Assessing the WBC. Timepoint: before and one month after beginning of intervention. Method of measurement: through laboratory techniques.;Assessing the hemoglobin. Timepoint: before and one month after beginning of intervention. Method of measurement: through laboratory techniques.;Assessing the hematocrit. Timepoint: before and one month after beginning of intervention. Method of measurement: through laboratory techniques.;Assessing the platelet. Timepoint: before and one month after beginning of intervention. Method of measurement: through laboratory techniques.;Assessing the BUN. Timepoint: before and one month after beginning of intervention. Method of measurement: through laboratory techniques.;Assessing the creatinine. Timepoint: before and one month after beginning of intervention. Method of measurement: through laboratory techniques.

—

Secondary

Measure	Time frame
Nothing. Timepoint: Nothing. Method of measurement: Nothing.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Nezamloo

Besat Hospital

nezamlo.ali@gmail.com+98 81 3264 0020

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026